India to South Africa: Amlodipine Export Trade Route
India has recorded 413 verified shipments of Amlodipine exported to South Africa, representing a combined trade value of $17.9M USD. This corridor is served by 42 active Indian exporters, with an average shipment value of $43.3K USD. The leading Indian exporter is IPCA LABORATORIES LIMITED, which accounts for 59% of total export value with 89 shipments worth $10.5M USD. On the buying side, NA is the largest importer in South Africa with $8.9M USD in purchases. The top 3 suppliers — IPCA LABORATORIES LIMITED, ALEMBIC PHARMACEUTICALS LIMITED, RUSAN PHARMA LIMITED — together control 74% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to South Africa Amlodipine corridor is one of India's established pharmaceutical export routes, with 413 shipments documented worth a combined $17.9M USD. The route is dominated by IPCA LABORATORIES LIMITED, which alone accounts for roughly 59% of all export value, reflecting the consolidated nature of India's amlodipine manufacturing sector.
Across 42 active suppliers, the average shipment value stands at $43.3K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 81% of all shipments, consistent with amlodipine's non-urgent bulk-order profile.
Shipment activity peaks during April–June, with an average transit time of 16 days port-to-port. The route has recorded an annual growth rate of 13.8%, placing it at rank #3 among India's top amlodipine export destinations globally.
On the import side, key buyers of Indian amlodipine in South Africa include NA, RANBAXY PHARMACEUTICALS, AUSTELL PHARMACEUTICALS PTY LTD and 69 others. NA is the single largest importer with 40 shipments valued at $8.9M USD.
